Canadian Investment Regulatory Organization Trade Resumption – WSP

Trading resumes in: Company: WSP Global Inc. TSX Symbol: WSP All Issues: Yes Resumption (ET): 8:00 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which […]

Canadian Investment Regulatory Organization Trade Resumption – ACD.DB

Trading resumes in: Company: Accord Financial Corp. TSX Symbol: ACD.DB All Issues: No Resumption (ET): 8:00 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which

Ex-Guard Launches Extreme-Duty Front-End Protection with Grille Guard for the RAMĀ® 2500 and 3500 Pickup Trucks

Ex-Guard continues to expand its line of extreme-duty front-end protection with the release of a newRam Grille Guard engineered for 2010 and newer RAM 2500 and 3500 trucks. Designed for drivers seeking a powerfulRam 2500 Grille Guard, Ram 3500 Grille Guard, or an extreme-duty Pickup Truck Grille Guard, the new FX-50BG3 delivers the same trusted

ID.me Announces Contract with CMS to Advance Access, Security, and User Experience on Medicare.gov

ID.me today announced it has entered into a contract with the Centers for Medicare & Medicaid Services (CMS) to enable secured access and improved user experience on Medicare.gov beginning in early 2026. Medicare beneficiaries will be able to verify their identity and sign in using ID.me, the next-generation digital identity wallet trusted by more than

Ambros Therapeutics Launches with $125 Million Series A Financing to Advance Neridronate Through Phase 3 Registrational Program for Complex Regional Pain Syndrome Type 1

— Neridronate granted FDA Breakthrough Therapy, Fast-Track, and Orphan Drug designations; pivotal Phase 3 trial planned to start in the first quarter of 2026 — Jay Hagan joins as Chief Executive Officer leading a seasoned late-stage development team and will serve on the Board alongside Co-Founder and Chairman Keith Katkin — Oversubscribed Series A financing

U.S. Legal Support’s AI-Powered Deposition Summaries Get Smarter with Timeline, Exhibits, and Deponent Insights

U.S. Legal Support, the nation's leading provider of litigation support services, excitedly announced the launch of enhanced features for its AI-powered deposition summary platform, DepoSummary Pro. The new features help legal professionals extract actionable insights from deposition transcripts, streamline case preparation, and make more informed, strategic decisions. https://mma.prnewswire.com/media/1222061/US_Legal_Support_Logo.jpg Key enhancements include: — Chronological Case Timeline:

EBANX: Six months after its launch, recurring Pix is growing at 41% per month, unlocking a new market for subscription-based global players

CURITIBA, Brazil, Dec. 16, 2025 (GLOBE NEWSWIRE) — Six months ago, approximately 60 million potential consumers in Brazil were mostly unreachable for subscription-based services, from video and music streaming to design and marketing platforms. This was not necessarily because they couldn't afford the services, but because they lacked a credit card, according to uncarded population

Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies

(NASDAQ:CLRB),(NASDAQ:CLRBW),(NASDAQ:CLRBZ), FLORHAM PARK, N.J. and LANSING, Mich., Dec. 16, 2025 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced a multi-year supply agreement with Ionetix Corporation, a leading cyclotron technology innovator and full-service radioisotope manufacturer, for

MediBeacon(R) Next Generation TGFR(TM) System Receives FDA Approval

(NYSE:VATE), MediBeacon(R) TGFRTM System is a first-in-kind product for point of care kidney function assessment Centers of Excellence commercialization in select academic medical centers begins in early 2026 NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) — INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that MediBeacon Inc. (“MediBeacon”), a medical technology company specializing

Scroll to Top